Suppr超能文献

全基因组分析揭示 TDG 在雌激素受体介导的增强子 RNA 转录和 3 维重排中的作用。

Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.

机构信息

Department of Biochemistry, Western University, London, ON, Canada.

Department of Oncology, Western University, London, ON, Canada.

出版信息

Epigenetics Chromatin. 2018 Jan 29;11(1):5. doi: 10.1186/s13072-018-0176-2.

Abstract

BACKGROUND

The estrogen receptor (ER) is a ligand-dependant transcription factor expressed in many breast cancers and is the target of many endocrine-based cancer therapies. Genome-wide studies have shown that the ER binds to gene-specific enhancer regions in response to β-estradiol (E2) which undergo transcription producing noncoding enhancer RNA (eRNA). While eRNAs are important for transcriptional activation of neighboring genes, the mechanism remains poorly understood.

RESULTS

Using ChIP-Seq we generate a global profile of thymine DNA glycosylase (TDG), an ER coactivator that plays an essential role in DNA demethylation, in response to E2 in the MCF7 breast cancer cell line. Remarkably, we found that in response to E2 TDG localized to enhancers which also recruit ERα, RNA Pol II and other coregulators and which are marked by histone modifications indicative of active enhancers. Importantly, depletion of TDG inhibits E2-mediated transcription of eRNAs and transcription of ER-target genes. Functionally, we find that TDG both sensitizes MCF7 cells to tamoxifen-mediated cytostasis and increases migration and invasion of MCF7 cells.

CONCLUSIONS

Taken together we find that TDG plays a central role in mediating transcription at a subset of enhancers and governs how MCF7 cells respond to both estrogenic and anti-estrogenic compounds and may be an effective therapeutic target.

摘要

背景

雌激素受体(ER)是许多乳腺癌中表达的配体依赖性转录因子,也是许多基于内分泌的癌症治疗的靶点。全基因组研究表明,ER 结合到基因特异性增强子区域,以响应β-雌二醇(E2),从而进行转录产生非编码增强子 RNA(eRNA)。虽然 eRNAs 对于邻近基因的转录激活很重要,但机制仍不清楚。

结果

我们使用 ChIP-Seq 生成了胸腺嘧啶 DNA 糖基化酶(TDG)的全局图谱,TDG 是一种 ER 共激活因子,在 DNA 去甲基化中发挥着重要作用,它对 MCF7 乳腺癌细胞系中的 E2 有反应。值得注意的是,我们发现,E2 响应时,TDG 定位于增强子,增强子也招募 ERα、RNA Pol II 和其他核心调节剂,并且被标记为活跃增强子的组蛋白修饰。重要的是,TDG 的耗竭抑制了 E2 介导的 eRNA 和 ER 靶基因的转录。功能上,我们发现 TDG 既使 MCF7 细胞对他莫昔芬介导的细胞停滞敏感,又增加 MCF7 细胞的迁移和侵袭。

结论

总之,我们发现 TDG 在介导一组增强子的转录中起着核心作用,并控制 MCF7 细胞对雌激素和抗雌激素化合物的反应方式,可能是一个有效的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b1/5787930/43f85a346bdc/13072_2018_176_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验